Decursin

CAT: 0804-HY-18981-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-18981-01Size:1 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Decursin ((+) -Decursin) is a potent anti-tumor agent. Decursin also is a cytotoxic agent and a potent protein kinase C activator. Decursin induces apoptosis and cell cycle arrest at G1 phase. Decursin decreases the expression of CDK2, CDK4, CDK6, cyclin D1 protein at 48 h. Decursin inhibits cell proliferation and migration. Decursin shows anti-tumor, anti-inflammatory and analgesic activities[1][2][3][4].
CAS Number
[5928-25-6]
Product Name Alternative
(+) -Decursin
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Apoptosis; CXCR; PKC
Type
Natural Products
Related Pathways
Apoptosis; Epigenetics; GPCR/G Protein; Immunology/Inflammation; TGF-beta/Smad
Applications
Cancer-programmed cell death
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Decursin.html
Purity
99.92
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
C/C(C)=C\C(O[C@H](C(C)(C)O1)CC2=C1C=C(O3)C(C=CC3=O)=C2)=O
Molecular Formula
C19H20O5
Molecular Weight
328.36
Precautions
H302, H315, H319
References & Citations
[1]Yim D, et al. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res. 2005 Feb 1;65 (3) :1035-44.|[2]Jung SY, et al. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function. J Cell Biochem. 2012 May;113 (5) :1478-87. |[3]Son DB, et al. Decursin Alleviates Mechanical Allodynia in a Paclitaxel-Induced Neuropathic Pain Mouse Model. Cells. 2021 Mar 4;10 (3) :547.|[4]Ahn KS, et al. Decursin: a cytotoxic agent and protein kinase C activator from the root of Angelica gigas. Planta Med. 1996 Feb;62 (1) :7-9.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported

Popular Products